My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
CareDx (CDNA)
NASDAQ:CDNA

CareDx Stock Analysis & Ratings

CareDx Stock Analysis Overview

Smart Score
1
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The CareDx stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

CDNA

CDNA Stock Stats

Previous Close$43.14
Open$44.26
Bid39.5 x 127
Ask45.67 x 69
Today’s Range$41.94 - $44.8
52-Week Range$39.16 - $99.83
Volume761.92K
Average Volume617.58K
Market Cap$2.22B
Beta0.56
P/E Ratio-123.3
EPS-0.35
Earnings DateMar 24, 2022

Company Description

CareDx

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Sector
Healthcare
Industry
Medical Diagnostics & Research
CEO
Reginald Seeto
Employees
475
ISIN
US14167L1035
Address
1 Tower Place, South San Francisco, CA, 94080, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

CDNA FAQ

What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $39.16 and its highest was $99.83 in the past 12 months.
    What is CareDx’s market cap?
    CareDx’s market cap is $2.22B.
      What is CareDx’s price target?
      The average price target for CareDx is $98.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $106.00 ,the lowest forecast is $90.00. The average price target represents 135.04% Increase from the current price of $41.98.
        What do analysts say about CareDx?
        CareDx’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
          When is CareDx’s upcoming earnings report date?
          CareDx’s upcoming earnings report date is Mar 24, 2022 which is in 112 days.
            How were CareDx’s earnings last quarter?
            CareDx released its earnings results on Oct 28, 2021. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.138 by -$0.092.
              Is CareDx overvalued?
              According to Wall Street analysts CareDx’s price is currently Undervalued.
                Does CareDx pay dividends?
                CareDx does not currently pay dividends.
                What is CareDx’s EPS estimate?
                CareDx’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does CareDx have?
                CareDx has 52,800,000 shares outstanding.
                  What happened to CareDx’s price movement after its last earnings report?
                  CareDx reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.138. Following the earnings report the stock price went down -24.344%.
                    Which hedge fund is a major shareholder of CareDx?
                    Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 216M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis